Canakinumab (ACZ885, a fully human IgG1 anti-IL-1?? mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS) 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Canakinumab (ACZ885, a fully human IgG1 anti-IL-1?? mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

摘要：